CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland
CTRIAL-IE (ICORG) 15-34:21基因乳腺癌复发评分®检测对爱尔兰雌激素受体阳性、淋巴结阳性早期乳腺癌化疗处方的影响
期刊:Irish Journal of Medical Science
影响因子:1.6
doi:10.1007/s11845-025-03922-7
Mullally, W J; Hassan, A; Keegan, N; O'Leary, C; McSorley, L; Mahgoub, T; O'Reilly, S; Walshe, J; Kennedy, M J; Coate, L; O'Connor, M; Keane, M; Kelly, C M; Duffy, K; Murphy, C G; Milewski, M; Molloy, S; Egan, K; Murphy, V; Breathnach, O S; Grogan, L; Hennessy, B T; Morris, P G